GE Healthcare(NASDAQ:GEHC) was initiated with a Neutral rating at J.P. Morgan due to strong imaging business and healthy margin in the foreseeable future.
J.P. Morgan set price target for GEHC at $90.
“Given good underlying secular trends, and a large ~$20B capital backlog, we feel comfortable that the business can sustain low- to mid-single-digit organic growth alongside healthy operating margin expansion for the foreseeable future.
While 2025+ should see above-trend growth, we think there is already a healthy amount of margin expansion built into consensus.” the research report said.
GEHC stock has risen 10.4% so far this year.
